The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

November 30, 2013

Conditions
Systemic Lupus ErythematosusWidespread PainFibromyalgia
Interventions
DRUG

Milnacipran

After dose escalations, patients will receive Milnacipran administered at 50 mg twice a day after for 12 weeks or milnacipran 50 mg twice day for 4 weeks and then 100 mg twice a day for an additional 6 weeks depending on tolerability and fatigue response.

Trial Locations (1)

92354

Loma Linda University Medical Center, Loma Linda

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Loma Linda University

OTHER